And a mountain of confusion sitting between them
For someone with cardiovascular disease, kidney disease, a history of pancreatitis, gallbladder issues, diabetic eye disease, thyroid cancer risk, or multiple medications, the decision becomes more individualized
Saurabh Jain, Vice President - Global Delivery Centers, Indegene and Vijay Charlu, President of Domestic Business, Corona Remedies to dissect who survives the shakeout, what it means for a slew of weight loss drugs in India, whether it will revolutionise metabolic treatment and whether India is truly ready for its statin moment....Read Less Transcript Host: Vikas Dandekar Also Listen Related Articles
RELATED: Ozempic vs
Interim Results from Ongoing Phase 2 COURAGE Trial Confirm Potential to Improve the Quality of Semaglutide (GLP-1 receptor agonist)-induced Weight Loss by Preserving Lean Mass
Because semaglutide slows stomach emptying, large meals may increase nausea, bloating, fullness, reflux, or vomiting